Skip to main content

Course info

Conferences and Meetings 2023 Highlights of ASH North America

2023 Highlights of ASH North America

Category: Conferences and Meetings
Short name: 2023HighlightsofASHNorthAmericaCompleteMeetingWebcast
Course start date: 01/26/2023
Course end date: 01/26/2024
Enrol Me

Description

Get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management and care strategies at Highlights of ASH. This is your chance to evaluate your diagnostic techniques and therapeutic approaches and discuss with leading hematology experts and colleagues how new research and clinical updates can be translated into new patient care strategies

Sections

General
0 activities

DescriptionGet a synopsis of the top hematology re...
Myelodysplastic Syndromes
Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia
ITP/TTP, Immune Hemolysis, and aHUS
Panel Discussion with Drs. Dezern, Rampal and Karp-Leaf
Venous Thromboembolism/Anticoagulation and Its Reversal
Disorders of Hemostasis
Acquired Bone Marrow Failure Syndromes
Panel Discussion with Drs. Spyropoulos, Manco-Johnson and Groarke
Sickle Cell Disease: Sickling and other Hemoglobinopathies
Hematopoietic Stem Cell Transplantation
Transfusion Medicine and Apheresis
Panel Discussion with Drs. Lebensburger, Kosuri and Sarode
Chronic Lymphocytic Leukemia
Lymphoma
Panel Discussion with Drs. Sun and Abramson
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Myeloma & Plasma Cell Dyscrasia
Panel Discussion with Drs. Pratz, Curran and Kourelis
Text and media area Text and media area
1
Mediasite Content Mediasite Content
19
Enrol Me
Price
Purchase Required
Member Price
$175.00
Non-Member Price
$350.00
Trainee Member Price
$15.00
Emeritus Member Price
$175.00
Duration
More than one hour
Accreditation
Not Accredited
Research
  • Clinical
  • Population Science
  • Pre-Clinical Models
  • Translational
Included Topics
  • Clinical practice
  • Emerging technologies
  • Global health
  • Guidelines
  • Health disparities
  • Health economics
  • Health outcomes
  • Hematopathology, laboratory medicine, images in hematology
  • Interdisciplinary collaboration
  • Racial and ethnic minorities
  • Supportive Care
  • Survivorship
  • Therapeutics - Biologics
  • Therapeutics - Cytotoxic chemotherapy
  • Therapeutics - Immunosuppression
  • Therapeutics - Immunotherapy
  • Therapeutics - Targeted therapy
  • Treating Fairly
  • Underserved populations
Learning Level
Level 4/Advanced Clinicians: Board-eligible hematologist refining clinical or research skills
Disease Types and Treatments
  • Bleeding disorders
  • Hematopoietic stem cell transplantation and cellular and gene therapies
  • Other topics in classical hematology
  • Platelet disorders
  • Red cell disorders
  • Thrombotic disorders
  • Transfusion medicine and apheresis
Bleeding Disorders
  • Acquired bleeding disorders
  • Inherited bleeding disorders
Inherited bleeding disorders
  • Hemophilia A and B
  • Hereditary hemorrhagic telangiectasia
Clonal Lymphoid Disorders
  • Lymphoid leukemias
  • Non-Hodgkin lymphoma
Lymphoid leukemias
  • Acute lymphoblastic leukemia
  • Chronic lymphocytic leukemia
Non-Hodgkin lymphoma
  • Diffuse large B-cell lymphoma
  • Follicular lymphoma
  • Other aggressive B-cell lymphomas (e.g. mantle cell lymphoma, Burkitt lymphoma)
  • T-cell lymphomas
Clonal myeloid disorders
  • Acute myeloid leukemia
  • Myelodysplastic syndromes
  • Myeloproliferative neoplasms
Acute myeloid leukemia
  • Acute myeloid leukemia (non-APL)
Myeloproliferative neoplasms
  • Chronic myeloid leukemia
  • Chronic myelomonocytic leukemia and MDS/MPN overlap disorders
  • Other myeloproliferative neoplasms
  • Polycythemia vera
  • Primary myelofibrosis
Hematopoietic stem cell transplantation and cellular and gene therapies
  • Adoptive cellular therapies
  • Allogeneic hematopoietic stem cell transplantation (e.g. donor selection)
  • Autologous hematopoietic stem cell transplantation
  • Gene therapies
  • Infectious considerations of HSCT and cellular and gene therapies
  • Late Complications
Adoptive cellular therapies
  • Chimeric antigen receptor T-cell therapies
  • Treatment-related adverse events
Infectious considerations of HSCT and cellular and gene therapies
  • Opportunistic infections
Late Complications
  • Clinical Results
  • Disease Recurrence
  • Survivorship
Other topics in classical hematology
  • Acquired and inherited non-malignant white cell disorders
  • Hematopoiesis and bone marrow failure syndromes
Acquired and inherited non-malignant white cell disorders
  • Disorders of neutrophil number or function
Hematopoiesis and bone marrow failure syndromes
  • Autoimmune aplastic anemia and other acquired bone marrow failure syndromes
  • Inherited bone marrow failure and myeloid malignancy predisposition syndromes
Plasma cell disorders
  • Multiple myeloma
Platelet disorders
  • Disorders of platelet number
Disorders of platelet number
  • Immune thrombocytopenia
  • Inherited thrombocytopenias
  • Other thrombocytopenias
  • Thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
Red Cell Disorders
  • Acquired anemias
  • Inherited anemias
Acquired anemias
  • Autoimmune hemolytic anemias
Inherited anemias
  • Sickle cell disorders
  • Thalassemias and other hemoglobin disorders
Thrombotic disorders
  • Antithrombotic therapy
  • Thromboembolism
  • Thrombophilia
Antithrombotic therapy
  • Anticoagulation
  • Antiplatelet therapy
Thrombophilia
  • Acquired thrombophilias
Thromboembolism
  • Arterial thromboembolism
  • Venous thromboembolism
Transfusion medicine and apheresis
  • Adverse effects of transfusion
  • Apheresis
  • Basics of transfusion medicine
  • Transfusion medicine in special populations
Adverse effects of transfusion
  • Delayed immune (e.g. delayed hemolytic, alloimmunization)
Apheresis
  • Therapeutic apheresis ( e.g., plasmapheresis, red cell exchange, leukapheresis)
Basics of transfusion medicine
  • Blood components and derivatives
  • Blood groups, pre-transfusion testing, antibody evaluation, donors
  • Blood product modifications
  • Clinical indications for transfusion
Transfusion medicine in special populations
  • Transfusion medicine in other special populations
  • Transfusion medicine in pediatrics and obstetrics (e.g., neonate/newborn, fetus)
  • Transfusion support in hematologic disorders (e.g., sickle cell disease, leukemia)

Tag

bleeding disorders classical hematology Clinical practice Clonal lymphoid disorders Clonal myeloid disorders Emerging technologies Global health Guidelines health disparities Health economics Health outcomes Hematopathology; laboratory medicine; images in he Hematopoietic stem cell transplantation and cellul Human populations - Adults (age 18-64) Human populations - age 18 Human populations- older adults (age 65+) Human populations - Women; pregnancy; maternal hea Interdisciplinary collaboration Patient experience Plasma cell disorders Platelet disorders Racial and ethnic minorities red cell disorders Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational Supportive Care Survivorship Therapeutics - Biologics Therapeutics - Cytotoxic chemotherapy Therapeutics - Immunosuppression Therapeutics - Targeted therapy Thrombotic disorders Transfusion medicine and apheresis Treating fairly Underserved populations